Lonial S - Search Results

1

A Phase 1 and 2 study of Filanesib alone and in combination with low-dose dexamethasone in relapsed/refractory multiple myeloma.

Shah JJ, Kaufman JL, Zonder JA, Cohen AD, Bensinger WI, Hilder BW, Rush SA, Walker DH, Tunquist BJ, Litwiler KS, Ptaszynski M, Orlowski RZ, Lonial S. Shah JJ, et al. Among authors: lonial s. Cancer. 2017 Dec 1;123(23):4617-4630. doi: 10.1002/cncr.30892. Epub 2017 Aug 17. Cancer. 2017. PMID: 28817190 Free PMC article. Clinical Trial.

2

Signal transduction and myeloma: new targets, new hope.

Lonial S, Waller EK, Simons JW, Heffner LT Jr. Lonial S, et al. Cancer Biol Ther. 2003 Jul-Aug;2(4):310-9. doi: 10.4161/cbt.2.4.425. Cancer Biol Ther. 2003. PMID: 14508098 Review.

3

Multiple myeloma: the role of transplant and novel treatment strategies.

Kaufman J, Lonial S. Kaufman J, et al. Among authors: lonial s. Semin Oncol. 2004 Apr;31(2 Suppl 4):99-105. doi: 10.1053/j.seminoncol.2004.02.015. Semin Oncol. 2004. PMID: 15124142 Review.

4

Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma.

Lonial S, Waller EK, Richardson PG, Jagannath S, Orlowski RZ, Giver CR, Jaye DL, Francis D, Giusti S, Torre C, Barlogie B, Berenson JR, Singhal S, Schenkein DP, Esseltine DL, Anderson J, Xiao H, Heffner LT, Anderson KC; SUMMIT/CREST Investigators. Lonial S, et al. Blood. 2005 Dec 1;106(12):3777-84. doi: 10.1182/blood-2005-03-1173. Epub 2005 Aug 11. Blood. 2005. PMID: 16099887 Free PMC article. Clinical Trial.

5

A practical update on the use of bortezomib in the management of multiple myeloma.

San Miguel J, Bladé J, Boccadoro M, Cavenagh J, Glasmacher A, Jagannath S, Lonial S, Orlowski RZ, Sonneveld P, Ludwig H. San Miguel J, et al. Among authors: lonial s. Oncologist. 2006 Jan;11(1):51-61. doi: 10.1634/theoncologist.11-1-51. Oncologist. 2006. PMID: 16401713 Free article. Review.

6

Novel treatment approaches for patients with multiple myeloma.

Sinha R, Kaufman JL, Lonial S. Sinha R, et al. Among authors: lonial s. Clin Lymphoma Myeloma. 2006 Jan;6(4):281-8. doi: 10.3816/CLM.2006.n.002. Clin Lymphoma Myeloma. 2006. PMID: 16507205 Review.

7

Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.

Brinker BT, Waller EK, Leong T, Heffner LT Jr, Redei I, Langston AA, Lonial S. Brinker BT, et al. Among authors: lonial s. Cancer. 2006 May 15;106(10):2171-80. doi: 10.1002/cncr.21852. Cancer. 2006. PMID: 16598756 Free article.

8

Proteasome inhibition: novel therapy for multiple myeloma.

Kaufman JL, Lonial S. Kaufman JL, et al. Among authors: lonial s. Onkologie. 2006 Apr;29(4):162-8. doi: 10.1159/000091692. Epub 2006 Mar 29. Onkologie. 2006. PMID: 16601373 Review.

9

Novel treatment approaches for patients with relapsed and refractory multiple myeloma.

Sinha R, Lonial S. Sinha R, et al. Among authors: lonial s. Curr Treat Options Oncol. 2006 May;7(3):246-57. doi: 10.1007/s11864-006-0017-6. Curr Treat Options Oncol. 2006. PMID: 16615880 Review.

10

Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma.

Lonial S, Arellano M, Hutcherson D, Langston A, Flowers C, Heffner LT, Winton E, Jo Lechowicz M, Waller EK. Lonial S, et al. Leuk Lymphoma. 2006 Oct;47(10):2155-62. doi: 10.1080/10428190600774923. Leuk Lymphoma. 2006. PMID: 17071490 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

458 results

Search Page